Skip to Content

Belimumab

In the US, Belimumab (belimumab systemic) is a member of the drug class selective immunosuppressants and is used to treat Systemic Lupus Erythematosus.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA26

CAS registry number (Chemical Abstracts Service)

0356547-88-1

Chemical Formula

C6714-H10428-N1816-O2102-S52

Therapeutic Categories

Selective immunosuppressant

Immunomodulator

Chemical Name

Immunoglobulin G1, anti-(human cytokine BAFF) (human monoclonal LymphoStat- heavy chain), disulfide with human monoclonal LymphoStat-B λ-chain, dimer (WHO )

Foreign Names

  • Belimumabum (Latin)
  • Belimumab (German)
  • Bélimumab (French)
  • Belimumab (Spanish)

Generic Names

Brand Names

  • Benlysta
    Glaxo Group, Austria; Glaxo Group, Cyprus; Glaxo Group, Iceland; Glaxo Group, Lithuania; Glaxo Group, Poland; Glaxo Group, Romania; Glaxo Group, Slovenia; Glaxo Group, Slovakia; GlaxoSmithKline, Australia; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Italy; GlaxoSmithKline, Macedonia; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, United States; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline UK, United Kingdom; GSK, Belgium; Wellcome Limited, Bosnia & Herzegowina

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide